By Andrew Silver SHANGHAI (Reuters) -German healthcare and materials group Merck KGaA has dropped a surcharge on life ...

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around ...

As per media reports in February, Merck Germany reacted to press reports and confirmed advanced discussions with SpringWorks Therapeutics. The offer represents a 26% premium over SpringWorks' 20 ...

Germany’s Merck KGaA agreed to acquire U.S. biopharmaceutical company SpringWorks Therapeutics for around $3.9 billion, in a bid to expand its oncology and rare disease business. The German life ...

NEW YORK/FRANKFURT (Reuters) - Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 billion to add rare cancer therapies ahead of ...

German science and technology firm Merck reported higher profits in its first quarter on Thursday, but trimmed its forecast ...

Trump has claimed the move could cut US drug prices by 30 to 80 percent. However, according to German consultancy ...

April 28, 2025 (GLOBE NEWSWIRE) -- Merck KGaA, Darmstadt, Germany (DAX: MRK), a leading science and technology company, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage ...

Merck KGaA, the German science and technology group, trimmed its profit forecast, citing a weakening US dollar and ...

During the meeting, Senator Dr. Rasha Kelej officially appointed H.E. Senator Oluremi Tinubu as the Ambassador of “Merck ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...